Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|November 5, 2019
Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast CancerXin Zhang, Zubiao Niu, Hongquan Qin, et al.International Journal of Clinical and Experimental Pathology|January 23, 2020
Genetic mutations in lung enteric adenocarcinoma identified using next-generation sequencingLi Lin, Wu Zhuang, Wenxian Wang, et al.Oncogenesis|June 16, 2018
CDKN2A inhibits formation of homotypic cell-in-cell structuresJianqing Liang, Jie Fan, Manna Wang, et al.Cancer Research|April 12, 2013
Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancerZhaofang Bai, Yanhong Tai, Weihua Li, et al.Cell Cycle (Georgetown, Tex.)|June 8, 2012
Repression of endometrial tumor growth by targeting SREBP1 and lipogenesisWeihua Li, Yanhong Tai, Jie Zhou, et al.Cell Cycle (Georgetown, Tex.)|March 5, 2013
Tumor-suppressive effects of CDK8 in endometrial cancer cellsWeiting Gu, Chenguang Wang, Weihua Li, et al.IUBMB Life|September 17, 2013
HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transitionXiaojie Xu, Chengying Jiang, Shibin Wang, et al.Nature Communications|March 21, 2026
Dalpiciclib plus chidamide in HR + /HER2-advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trialJinmei Zhou, Xuexue Wu, Yimeng Du, et al.Cell Death & Disease|April 25, 2026
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasisHaoyuan Shi, Jiaxin Chen, Zisheng Wu, et al.Frontiers in Cellular and Infection Microbiology|March 20, 2023
BPOZ-2 is a negative regulator of the NLPR3 inflammasome contributing to SARS-CoV-2-induced hyperinflammationJingfei Li, Haotian Lin, Tinghui Fan, et al.Pageof 5